Her program of research, which has been continuously funded by the National Institutes of Health since 2001, focuses on the role for neurotrophin signaling in chronic pain plasticity and muscle function. In addition, she and her group utilize genetic and other “omics” approaches to discover novel therapeutic targets for the treatment of chronic pain. She is a member of Pi Chapter.